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Laryngological and Dental 
Manifestations of Sjögren’s 
Syndrome
Bartłomiej Kamiński and Katarzyna Błochowiak
Abstract
Sjögren’s syndrome (SS) affects numerous different areas, and many special-
ists may be involved in the diagnosis and treatment of SS. Otolaryngological and 
dental manifestations, neurological impairment, and hearing loss may be the initial 
symptoms of SS. This chapter describes the most common otolaryngological and 
oral manifestations of SS, its pathomechanism and possible etiology. Dryness 
accompanying SS is associated with many clinical implications. The rate of dry 
mouth in SS ranged from 41% at initial diagnosis to 84% 10 years after diagnosis. An 
unstimulated salivary flow rate of 0.1 ml/min in sialometry gives a score of 1 to the 
weighted sum of 5 items according to the current EULAR/ACR criteria. The presence 
of mononuclear cell aggregates around the ducts and acini of salivary glands results 
in functional and structural alterations at the level of these glands and impairs their 
secretory function. The most common oral signs and symptoms are dental caries, 
tooth decay, fungal infections, traumatic oral lesions, dysphagia, dysgeusia, and 
inflammation of the salivary glands. Saliva in SS is characterized by the increased 
concentration of lactoferrin, potassium and cystatin C and the decreased concentra-
tion of amylase, carbonic anhydrase, mucins, histatines, IgA, statherins, proline-rich 
proteins, and the loss of salivary buffer properties. The lack of these physiological 
defense mechanisms increases the risk of opportunistic infections, mainly fungal 
infections by Candida albicans. Candidiasis accompanies angular cheilitis, simple 
cheilitis, and exfoliative cheilitis. The salivary glands of SS patients are character-
ized by chronic inflammation with the presence of lymphocytic infiltrates located 
around the striated ducts. These periductal foci may lead to the development of 
organized ectopic lymphoid structures resembling secondary lymphoid organs 
with segregated T- and B-cell areas, and high endothelial venules. These structures 
become an active center of immune response. The presence of foci in labial salivary 
glands is a hallmark of SS, and their histopathologic analysis is an important item 
in the diagnosis and classification. A biopsy can be taken from either the labial or 
the parotid salivary gland, but currently according to the diagnostic criteria, only 
labial salivary gland biopsy (LSGB) is recommended to confirm the diagnosis of 
SS. The authors present their own experience and recommendations in taking labial 
salivary gland biopsy, the main surgical approaches, and the main limitations for this 
diagnostic method and describe the possibilities and principles of histopathological 
examination in SS. The authors present the main ultrasonic signs of SS major sali-
vary glands and perspectives of the usage of salivary gland ultrasonic examination 
in the diagnosis and monitoring of SS. The presented chapter also includes the most 
common laryngological manifestations associated with SS: nose dryness, crusting, 
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or atrophy of the nasal mucosa, dryness of the throat, dysphagia, hoarseness, otalgia 
and tinnitus, gastro-esophageal reflux, and chronic cough. Patients with SS tend to 
have a higher prevalence of sensorineural hearing impairment compared with the 
general population. Idiopathic hearing loss may represent the initial manifestation 
of SS. Furthermore, authors present and discuss the main neurological symptoms 
of SS. Neurological manifestations are reported in about 20% of patients with SS. In 
patients with SS, neurological manifestations may occur, such as peripheral neu-
ropathy and other forms of neuropathies, including sensory ataxia, painful sensory 
neuropathy without sensory ataxia, multiple mononeuropathy, multiple cranial 
neuropathy, autonomic neuropathy, radiculoneuropathy and intra- and extraoral 
paresthesias, facial hypaesthesia, and trigeminal nerve neuropathy.
Keywords: Sjögren’s syndrome, hearing loss, cranial nerve neuropathy, xerostomia
1. Introduction
Microscopic findings involving lymphocytic infiltration surrounding the 
excretory ducts in combination with the destruction of acinar tissue are representa-
tive for both minor and major salivary glands and are pathognomonic changes for 
SS. Parotid, lip, or sublingual salivary gland biopsy is performed in the diagnosis 
and monitoring of SS, but currently only labial salivary gland biopsy (LSGB) is 
included into classification criteria of SS. LSGB is used for the diagnosis of Sjögren’s 
syndrome (SS). The current classification criteria of SS, approved by the American 
College of Rheumatology (ACR) and the European League against Rheumatism 
(EULAR) in 2016, include LSGB as a part of weighted sum of five items [1]. The 
presence of focal lymphocytic sialadenitis (FLS) with a focus score of 1 foci/4 mm2 
glandular tissue is a positive score of LSGB. Lip salivary glands are widely distrib-
uted in the labial mucosa of the oral cavity. They are largely used for assisting the 
diagnosis of SS, because they are easily accessible and lie above the muscle layer. 
They are separated from the oral mucous membrane by a thin layer of fibrous con-
nective tissue. Orientation and identification of glandular tissue is the easiest. The 
risk of excessive postoperative bleeding is decreased because the arterial supply to 
the lip lies deep. These anatomical implications and pathognomic changes predis-
pose of labial salivary glands to the biopsy [1–7].
2. Surgical technique and possible complications of LSGB
Labial salivary gland biopsy is considered a minor surgical procedure and can be 
performed on the ambulatory basis. There is no standardized technique that yields 
adequate tissue for analysis and minimizes adverse effects. The lack of uniformity in 
methodology and potential adverse effects of LSGB hinders its application. LSGB is 
treated as a safe and simple surgical procedure without severe postoperative compli-
cations. One of the most severe complications of LSGB is sensitive nerve injury. This 
localized sensory alternation can be described as an anesthesia, a reduced or partial 
loss of sensation, a transitory numbness, or a hypoesthesia. These sensations can last 
for a few months or can be permanent. Persistent lip numbness occurs in up to 6% of 
biopsies performed in the lower lip [8]. The branches of the mental nerve in the lower 
lip are closely associated with the salivary glands, and this anatomical relationship 
increases the risk of postoperative sensory sensations. Additionally, the branch of the 
mental nerve usually divides into two sub-branches: a horizontal and a vertical, which 
have an ascending course toward the vermillion border and are in close relation to the 
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labial salivary glands. Incisional biopsies shorter than 2 cm performed with a scalpel 
have reported complications ranging from 0 to 9.3%, whereas those using larger 
incisions (2–3 cm) have described complications in the range of 3.7–31%. Transient 
disorders of lip sensitivity are found to occur in up to 11.7% of procedures. Persistent 
lower lip hypoesthesia is reported in about 3.4–4% of cases. Larger incisional biopsies 
and punch biopsies are associated with a higher risk of both transient and persistent 
lower lip numbness. Other possible complications of LSGB are less severe, usually 
transient or temporary, and are associated with localized postoperative inflammation 
or improper healing. The symptoms of postoperative inflammations are local pain 
and swelling. Blood vessel injuries result in hematoma. The possible delayed compli-
cations are the formation of granulomas, internal scarring, and cheloid formation. 
Labial salivary gland injuries can result in mucous extravasation cysts. Some patients 
can report burning or tingling sensations, and functional deficits during the immedi-
ate postbiopsy period such as eating, sleeping, or speech difficulties [9–12].
Labial glands biopsy may be an excisional or incisional technique. The most rec-
ommended site is normal-appearing mucosa of the lower lip. Usually, it is a scalpel 
biopsy. A wide range of surgical approaches have been described for harvesting a few 
accessory glands from the lower lip using different instruments such as a scalpel, a 
punch, or cup forceps. The use of a forceps with a fenestrated active end to stabilize 
the lip has also been suggested. The excisional biopsy is carried out by excising an 
ellipse of oral mucous membrane down to the muscle layer. Ideally, 6–8 minor glands 
must be harvested and sent for histopathologic examination. The wound should be 
closed with 4-0 silk sutures, which are removed after 4–5 days. The modification of 
this method is the technique with a mucosal excision of 3.0 × 0.75 cm. Another rec-
ommended technique is a 1.0–1.5-cm-wedge-shaped excision of the mucosa between 
the midline and commissure. The incisional biopsy is described as a 1.5–2.0-cm 
linear incision of mucosa, parallel to the vermillion border and lateral to the midline. 
Gorson and Ropper reported a 1-cm vertical incision just behind the wet line through 
the mucosa and submucosa [31]. It is usually that case that the lateral lip compart-
ments are advocated for biopsy, because of the glandular-free zone in the center of 
the lower lip. Berquin et al. described an oblique incision, starting 1.5 cm from the 
midline and proceeding latero-inferiorly to avoid the central glandular-free zone. 
The vertical incision technique is associated with less pain, less swelling, less scar 
formation, and less difficulty in eating when compared with the horizontal incision 
technique. There is insufficient evidence to support the superiority of one technique 
over the others, and the shape and the size of the incision can be considered a matter 
of preference. The incision shape includes elliptical, circular, linear, horizontal, verti-
cal, and wedge shapes, and the incision length varies from a few millimeters to 2 cm.
Another recommended modification is using loupe operation glasses to precisely 
excise the salivary glands without disturbing the direct underlying sensible nerves. 
The alternative technique to scalpel biopsy is the minor salivary gland punch 
biopsy. This biopsy can be performed by a single operator, and it is less expensive 
than classical scalpel biopsy. This technique consists of obtaining the biopsy from 
the buccal side of the lower lip, which is stabilized by the patient him/herself using 
a 4–5 mm punch, which permits the retrieval of a cylinder of tissue up to 8 mm in 
length. The punch biopsy is suggested because of the absence of risk to the patient 
and because of its simplicity. However, the punch biopsies do not provide enough 
material for the diagnosis of Sjögren’s syndrome. Moreover, the findings of this 
study strongly discouraged the punch technique for minor salivary gland lip biopsy 
and provided information on the superiority of the linear incisional biopsy in terms 
of neural damage [12–16].
Based on our own clinical experience, a 1.0–1.5-cm linear, horizontal incision 
of mucosa parallel to the vermillion border and lateral to the midline with the 
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tip of a 15 scalpel is worth to recommend. The lower lip should be retracted and 
everted under tension to expose the inner surface and allow visualization of the 
minor salivary glands just to the depth of the mucosa. Local anesthesia injected 
submucosally with 0.5–1.0 ml of 1% lidocaine with 1:200,000 epinephrine is suf-
ficient. The anesthesia hydrodissects and lifts the mucosa away from the salivary 
glands, provides delivery of local anesthetic directly to sensory nerve fibers, and 
temporarily displaces small vessels deep in the glands to promote hemostasis and 
visualization during the dissection. In this technique, both margins of incision 
should be gently crafted to access the submucosal layer. This stage of procedure can 
be performed using blunt-tipped iris scissors or a scalpel by spreading in a plane 
perpendicular to the mucosal incision and parallel to the direction of the sensory 
nerve fibers. This technique is fast, simple, and leaves a small scar. The linear 
incision secures a good adherence of wound margins and proper and fast healing. 
Unfortunately, this method is not effective in small amounts of salivary glands. 
Sometimes, it is difficult to find the sufficient amount of labial glands. Moreover, it 
may be difficult to harvest a sufficient number of labial salivary glands in atrophic 
mucosa of patients with long-standing SS. In these cases, the recommended method 
is a 1-cm lenticular incision of mucosa, lateral to the midline, and removal of the 
mucosa to uncover the submucosal layer and obtain a few adjacent salivary glands. 
This technique ensures good visibility into the operating field to avoid blood vessels 
and nerve injures. This incision provides adequate glandular tissue for diagnosis. 
The wound should be closed by a few nonresorbable, single, interrupted stitches. 
One very important issue is to harvest only labial salivary glands without muscular 
or other tissues. It is the most valuable specimen for histopathological examination, 
because it only includes glandular tissue. Additionally, this technique decreases 
the risk of nerve damage and postoperative pain and assures successful healing. 
Sensory nerve fibers are almost always visible just below the plane of dissection, 
and care should be taken to identify and preserve them. The next very important 
issue is not to puncture the labial glands to reduce the risk of mucous extravasation 
cyst formation. It is even better to remove all visible labial salivary glands from the 
operating field before suturing in order not to damage the glands or their ducts. 
Patients should also avoid taking steroids before the biopsy. The factors potentially 
contributing to a false-negative rate include the use of oral steroids that may result 
in immunosuppression and confound histopathologic results. The tissue specimens 
should be immediately placed in a wide-mouthed container, coded, and fixed in a 
generous amount of 10% formalin buffered saline for 24 h (Figures 1 and 2).
Figure 1. 
Linear incision and scalpel biopsy of labial salivary gland biopsy. A few labial salivary glands exposed and 
visible in the operating field.
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3. Histologic criteria for diagnosis of SS on labial salivary gland biopsies
Labial salivary gland biopsy is an objective test of SS and plays a significant 
role in the diagnostic process. In fact, the presence of either anti-SSA/SSB sero-
positivity or a positive lip biopsy is a requirement for an individual to be classified 
as having SS. The microscopic confirmation of SS is based on the presence of focal 
lymphocytic sialadenitis (FLS) with a focus score ≥ 1 per 4 mm2 of glandular 
tissue. According to the revised American-European Consensus Group’s (AECG) 
classification criteria and the ACR classification criteria for SS, an LSGB is consid-
ered positive if minor salivary glands demonstrate FLS, with a focus score of 1 or 
more, as evaluated by an expert histopathologist. A lymphocytic focus is defined 
as a dense aggregate of 50 or more lymphocytes adjacent to normal-appearing 
mucous acini in salivary gland lobules that lacked ductal dilatation. Focal lym-
phocytic sialadenitis is applied to specimens that show the presence of 1 or more 
foci of lymphocytes located in periductal and perivascular locations. The foci 
can contain plasma cells, but these must be a minority constituent of the inflam-
matory infiltrate. The focus score can be calculated for those specimens showing 
the histopathologic appearance of FLS. The number of lymphocytic foci is then 
determined for all the gland lobules in a single tissue section. The focus score is 
then calculated as the number of foci per square millimeter of glandular tissue 
multiplied by four, which then yields foci/4mm2. A focus score of 1 equates to 1 
focus/4 mm2. To determine the focus, a calibrated eyepiece grid or image analysis 
software with a closed polygon tool is used. FLS has to be distinguished from non-
specific chronic sialadenitis. The symptoms of nonspecific sialadenitis are mild to 
moderate acinar atrophy, interstitial fibrosis, and ductal dilatation, with lympho-
cytes and macrophages often scattered in the parenchyma, but not forming dense 
aggregates of 50 or more lymphocytes immediately adjacent to normal-appearing 
acini. In addition to the focus score (FS), two scoring systems for salivary glands 
are in use for the diagnosis and classification of SS. These systems are based on the 
presence of foci [7]. Grading according to Tarpley’s system involves destruction 
of acinar tissue and fibrosis (Table 1). Grading according to the Chisholm and 
Mason system is based on the presence of infiltrates from slight to one or more 
foci (Table 2) [16, 17].
Focus: a cluster of 50 or more lymphocytes and histiocytes.
Aggregate: approximately 50 cells (lymphocytes, plasma cells, or histiocytes).
Figure 2. 
Labial salivary gland specimen.
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4. Differentiation of focus lymphocytic sialadenitis
Focus lymphocytic sialadenitis should be differentiated with other microscopic 
findings:
• Nonspecific chronic sialadenitis NSCS
• Sclerosing chronic sialadenitis SCS
• Granulomatous inflammation
• Infiltrates within normal limits
• Marginal zone (MALT) lymphoma
• Germinal center
Nonspecific chronic sialadenitis (NSCN) is characterized by scattered or focal 
infiltrates of lymphocytes, macrophages, and plasma cells that are not adjacent to 
normal-appearing acini and located in gland lobules that exhibit some combination 
of acinar atrophy, interstitial fibrosis, duct dilation, and luminal inspissated mucus.
Sclerosing chronic sialadenitis (SCS) is an advanced stage of NSCS in which 
interstitial fibrosis, various patterns of chronic inflammation, and acinar atrophy 
predominate.
Granulomatous inflammation is present when there are clusters of CD68 posi-
tive macrophages, with or without occasional multinucleated giant cells and absent 
necrosis.
Infiltrates within normal limits can be diagnosed in minor salivary glands with 
normal appearing architecture and scattered plasma cells, but without acinar 
atrophy and few if any lymphocytes.
Grade Description
0 Absent
1 Slight infiltrate
2 Moderate infiltrate or less than one focus
3 One focus
4 More than one focus
Table 2. 
Grading systems for salivary gland biopsies of Chisholm and Mason.
Grade Description
0 Normal
1 1 or 2 Aggregates
2 >3 Aggregates
3 Diffuse infiltrate with partial destruction of acinar tissue with or without fibrosis
4 Diffuse infiltrate with or without fibrosis destroying the lobular architecture completely
Table 1. 
Grading systems for salivary gland biopsies of Tarpley.
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Marginal zone (MALT) lymphoma is diagnosed in minor salivary glands exhibit-
ing diffuse lymphocytic infiltration with loss of glandular architecture and com-
posed of sheets of CD20 positive cells without follicular distribution, few scattered 
CD3 positive cells, and few if any follicular dendritic (CD21 or CD23 positive) cells.
Germinal center presence is estimated in hematoxylin and eosin (H&E) stained 
sections by the presence of a cluster of relatively clear staining cells within a lym-
phocytic focus. More specific identification of germinal centers requires immuno-
histochemical staining for follicular dendritic cells with anti-CD21 or CD23 [4, 9].
There is no standardization of labial salivary gland biopsies in SS, but there are 
several points of importance in LSGB. The first issue refers to a sufficient amount of 
glandular tissue. A reasonable compromise is four glands, although a minimum sized 
evaluable surface area (8 mm2) may be achieved with 2–3 glands. The largest possible 
area to be sampled would give the best results, but a larger operative field increases the 
surgical risk. On the other hand, some glands may be atrophic or damaged, and the vol-
ume of the material obtained through the biopsy should be sufficient to overcome this 
artifact and achieve a valid result. It is more recommended to evaluate multiple differ-
ent lobules than to concentrate on a single abnormal lobule, which may not be typical 
of the entire gland. In routine management, H&E staining is used in order to determine 
these structures. For clinical trials, additional staining with CD21 as well as CD20 and 
CD3 is required. CD21 is a marker of follicular dendritic cells. Germinal centers should 
be reported and pathologists are advised to use caution in order to avoid overestimat-
ing germinal centers by relying solely on CD21. Furthermore, the distribution of the 
inflammatory cells in the gland may be uneven. Considering this uneven distribution, a 
single tissue section may result in underdiagnosis. While increasing the number of sec-
tions has the potential to reduce this problem, the optimal number of sections has yet to 
be determined. Some research suggests taking labial salivary glands at different depths 
from the same incision. Focus score can change significantly at different tissue depths 
within the minor salivary glands. Multiple sections for LSGB increase the diagnostic 
value and are more representative than a single section [7, 10] (Figure 3).
5. Limitations of the assessment of focus score
• Differentiation of FLS with nonspecific chronic sialadenitis and sclerosing 
chronic sialadenitis
• Severe acinar atrophy, interstitial fibrosis, and increase in fat cells in biopsy 
specimens
Figure 3. 
Confirmation of SS in LSGB. Focus score 4 (staining H&E, magnitude 10×).
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• Age-related features in biopsy specimens (increased fibrosis, acinar atrophy, 
and adipose tissue
• Lack of the measurement of the infiltrate [7]
6. Other histopathological features of LSGB
There are also other histopathological features in the labial glands that are asso-
ciated with SS and therefore might be indicative of this disease. Lymphoepithelial 
lesions (LELs) are striated ducts, which are infiltrated by lymphocytes with concur-
rent hyperplasia of the epithelial cells. They are found both in parotid and labial 
glands, and are more representative of parotid glands than labial glands.
Severity of the LELs can be classified into three stages: stage 1: a partial LEL 
(affecting <50% of the epithelium), stage 2: developed LELS (affecting 50–100% 
of the epithelium), and stage 3: occluded LELs (fully circumferentially affected 
epithelium without lumen).
Besides LELs, the salivary gland of SS patients also presents a relative decrease 
in IgA + plasma cells. Several studies showed that a relative decrease of <70% 
IgA + plasma cells was more sensitive and more disease specific than the FS. Both 
features can help assess the salivary gland biopsies for the diagnosis of SS, especially 
when the FS in the biopsy is <1 [7, 19–23].
7. Alternative types of salivary gland biopsies in SS
The main alternative types of salivary gland biopsies in SS are parotid gland 
biopsy and sublingual gland biopsy. Parotid gland biopsy allows the clinician to 
monitor the disease progression and to assess the effect of an intervention treat-
ment in SS. Parotid tissue can be harvested easily, repeated biopsies from the same 
parotid gland are possible, and the histopathologic results can be compared with 
other diagnostic results derived from the same gland, such as secretory function, 
sialographic appearance, and ultrasonography. Furthermore, parotid biopsy is 
better in the identification of lymphomas. The main possible complications are 
facial nerve damage, Frey’s syndrome, and development of sialoceles and salivary 
fistulae. A temporary change in sensation in the skin area of the incision is also 
a well-documented complication after parotid biopsy. Some patients might also 
develop preauricular hypothesis, although this is usually temporary. Furthermore, 
in SS, the salivary gland tissue is replaced by fatty tissue, and the risk of harvesting 
fatty tissue is thereby increased if done by inexperienced physicians. Parotid biopsy 
is particularly recommended in pediatric patients in whom SS is suspected and who 
have a negative minor salivary gland biopsy result. Incisional biopsy of the parotid 
gland overcomes most of the disadvantages of labial biopsy. When evaluating the 
parotid and labial biopsy, sensitivity and specificity are comparable, estimated to 
be 78 and 86%, respectively. Comparative studies suggest that both procedures— 
sublingual and parotid biopsy—retain a diagnostic potential comparable to that of 
lip biopsy and may be associated with lower postoperative morbidity. A comparison 
of sublingual gland biopsy with labial gland biopsy is better than that of labial 
gland biopsy, whereas the specificity of the latter is greater than that of the former. 
Sublingual gland biopsy is a relatively safe procedure, although the postoperative 
complications of sublingual salivary gland biopsy include ligaturing the Wharton 
duct, resulting from the placement of sutures, bleeding, and swelling in the floor of 
the mouth. Damage to the lingual nerve related to this biopsy technique has never 
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been reported in the literature. No specialized histopathologic criteria have been 
established for the diagnosis of SS after a sublingual gland biopsy, and researchers 
merely used the criteria for labial gland biopsies [24–28].
8. Oral involvement and xerostomia
The rate of dry mouth in SS ranged from 41% at initial diagnosis to 84% 10 years 
after diagnosis. Hyposalivation or xerostomia measured by sialometry is one of the 
objective clinical criteria in the diagnosis of SS. According to the current classifica-
tion criteria of SS, an unstimulated salivary flow rate of 0.1 ml/minute in sialometry 
gives a score of 1 to the weighted sum of 5 items. Dryness is also a subjective symp-
tom of SS and is associated with many clinical implications. There are two possible 
sources of hyposalivation. The first possible origin is the presence of mononuclear 
cell aggregates around the ducts and acini of salivary glands resulting in functional 
and structural alterations of these glands and impairing their secretory function. 
In addition to the direct relationship between mononuclear cell infiltrations and 
secretory function, there are alternative pathways, such as induction of apoptosis of 
epithelial glands, alterations in aquaporin distribution, or inhibition of neurotrans-
mission by antimuscarinic antibodies, lead to impaired glandular homeostasis. The 
second proposed hypothesis is the destruction of the duct and acinar cells of the 
salivary glands, and neural degeneration and/or the inhibition of nerve transmis-
sion. Hyposialia or decreased salivation can lead to xerostomia with clinical oral 
symptoms [29]. Dry mouth is associated with both objective and subjective signs 
and symptoms. The most common complaints related to dry mouth are presented in 
Table 3.
In SS, the gingiva and mucosa of the oral cavity are not protected by salivary 
mucins, leading to less lubrication of the tissues. This can cause signs such as oral 
mucosal inflammation, mucosal sloughing, erythematous mucosa, and traumatic 
ulcers. Patients may demonstrate depapillation of the tongue in advanced cases. 
With time, the concentration of lactoferrin, potassium and cystatin C in saliva 
grows, while the amylase and carbonic anhydrase concentration drops. Decreased 
secretion of saliva, the loss of its buffer properties, and a lower concentration of 
saliva proteins such as histatins, mucins, IgA, and proteins rich in proline and 
statherins increase the risk of opportunistic infections, mainly fungal infections 
by Candida albicans. The prevalence of Candida albicans is >68% in patients 
with SS. Oral candidiasis may be asymptomatic or may show as fissured tongue, 
rhomboid mid-tongue, nonspecific ulcerations, prosthetic stomatopathies, or 
generalized candidiasis. It most often takes the form of chronic candidiasis, and 
less often of pseudodiphtheritic candidiasis. Candida infections often present as 
atrophic or erythematous candidiasis and are associated with a burning mouth, 
which is described by approximately one-third of patients with SS. In SS patients, 
A dryness of the mouth in the morning and at night
A frequent need to sip water
A lip dryness, exfoliation, fissuring
A predisposition to aphthae, ulcers, and mouth sores
A burning sensation in the mouth
A dysphagia
A dysgeusia
Table 3. 
The most common complaints related to dry mouth.
Chronic Autoimmune Epithelitis - Sjogren’s Syndrome and Other Autoimmune Diseases...
10
C. albicans, C. tropicalis, C. glabrata, and C. parapsilosis are mainly isolated. Apart 
from oral candidiasis, a number of other changes and symptoms regarding the oral 
mucosa may occur (Table 4).
Angular cheilitis may be accompanied with fungal infection. In simple cheilitis, 
dominant manifestations are lip exfoliation and cracking, their proneness to bleed-
ing, periodic swelling, and burning. The lesions are mostly limited to lip vermillion, 
less often labial mucosa or the facial skin around the vermillion is affected. In 
exfoliative cheilitis, thick brown keratin plaques are also formed. Skin redness over 
the lip vermillion and swelling are more often observed [29].
SS patients are predisposed to rampant caries and traumatic oral lesions. Lack 
of antibacterial salivary proteins results in severe tooth caries, especially on the 
unexposed tooth spaces. Rampant cervical caries is the most typical manifestation 
to SS.
9. Laryngological and otological manifestations of SS
The lymphocytic infiltrations are representative for all salivary glands and have 
other possible consequences. Although the sicca syndrome prevails, in a clini-
cal presentation, a bilateral parotid swelling induced by progressive lymphocyte 
infiltration leads both to ductal inflammation and acinar destruction in about 50% 
of patients. Recurrent swelling and inflammations of the parotid or submandibular 
glands in SS are well documented. Slow salivary flow, acinar destruction, and lym-
phocytic infiltrations predispose to inflammation and salivary gland enlargement. 
This enlargement should be distinguished from lymphomas. The most significant 
complication of SS is the development of lymphoproliferative malignancy, which 
occurs in about 5% of SS patients. Malignant lymphoma, particularly mucosa- 
associated lymphoid tissue (MALT) lymphoma, is relatively a frequent complication 
of SS with an incidence ranging between 5 and 10% and a median time from SS to 
lymphoma diagnosis of 7.5 years. Lymphomas accompanying SS can be confirmed 
by histopathological examination of salivary gland biopsy. The detection of ger-
minal centers (GC) in salivary gland biopsy can be a very sensitive and predictive 
feature for lymphogenesis. Antigen-driven B cell selection normally takes place in 
GC within secondary lymphoid organs, but there is conclusive evidence that also 
ectopic GC in the salivary glands of SS patients allow affinity maturation of GC B 
cells with somatic Ig gene hypermaturation. Parotid gland biopsy is more recom-
mended for diagnosis of lymphomas than labial salivary glands [7, 18–23].
Dryness of the mucosa of the upper respiratory tract is a predominant symptom 
and results in nasal, oropharynx, nasopharynx, laryngopharynx, vocal cord dry-
ness, and dryness of the skin of the external auditory meatus. The main laryngo-
logical symptoms accompanying SS include the following:
Candidiasis
Angular cheilitis
Simple cheilitis
Exfoliative cheilitis
Aphthae
Aphthoid lesions
Nonspecific ulcerations
Paleness of the oral mucosa
Staphylococcal infection
Table 4. 
Symptoms of oral mucosa in the Sjögren’s syndrome.
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• Dry nose with congestion, crusting, and epistaxis
• Dryness, crusting, or atrophy of the nasal mucosa
• Soreness and/or dryness of the throat
• Viscid secretions on the posterior pharyngeal wall and tenacious mucus over 
the vocal cords
• Dry wax and a “milky” appearance of the tympanic membrane
• Dysphagia
• Hoarseness
• Otalgia
• Tinnitus
• A chronic dry cough
• Dyspnea
• Gastrotracheal reflux
• Otitis externa
• Myringitis
• Sensorineural hearing loss
• Facial hypaesthesia and trigeminal nerve neuropathy, and multiple cranial 
neuropathy [30–33]
Other possible laryngological manifestations of SS are early and progressive 
hearing loss and symptoms related to neuropathy of the eighth cranial nerve. 
Approximately, a quarter of patients suffer from high-frequency hearing loss of 
cochlear origin, as detected by impedance audiometry or auditory brainstem proce-
dures. The immunologic theory of sensorineural hearing loss (SNHL) in SS is based 
on antibody activity and cytotoxic T-cell-mediated apoptosis in the inner ear. It has 
been suggested that these autoantibodies induce thrombosis in the labyrinthine 
vessels, thereby causing damage to the inner ear, resulting in SNHL. The majority of 
primary SS patients exhibit hearing impairments of cochlear origin, principally at 
high frequencies. Sensorineural damage may be attributable to vasculitis or neuritis, 
or may represent an ototoxic effect of the drugs used to treat primary SS. Although 
there is no evidence of damage to the central auditory pathways in SS, these patients 
tend to have a higher prevalence of sensorineural hearing impairment compared 
with the general population. Idiopathic hearing loss may represent the initial mani-
festation of systemic vasculitis, including SS. The pathomechanisms underlying 
cranial neuropathy in SS have not yet been explained, except for trigeminal neu-
ropathy due to ganglionopathy. The two possible mechanisms, vascular origin with 
damage to the vasa nervorum, and an immunologic cause inducing lymphocytic 
infiltration of the nerve have been suggested in nerve palsies related to SS. Vasculitis 
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in peripheral neuropathy and ganglionopathy in trigeminal or ataxic neuropathies 
have been reported as the main pathogenic etiology. The rapid and almost complete 
recovery from nerve palsy after therapy with corticosteroids and azathioprine sug-
gests that lymphocytic infiltrate, rather than a vasculitic process, was the cause of 
cranial neuropathy in SS [33–40].
Author details
Bartłomiej Kamiński1* and Katarzyna Błochowiak2
1 Department of Otolaryngology, District Hospital, Skarzysko-Kamienna, Poland
2 Department of Oral Surgery, Poznan University of Medical Sciences, Poznan, 
Poland
*Address all correspondence to: bartl.kaminski@gmail.com
13
Laryngological and Dental Manifestations of Sjögren’s Syndrome
DOI: http://dx.doi.org/10.5772/intechopen.85687
References
[1] Shiboski CH, Shiboski SC, Seror R. 
2016 America College of Rheumatology/
European League Against Rheumatism 
Classification Criteria for primary 
Sjögren’s syndrome. Arthritis & 
Rhematology. 2017;69:35-45
[2] Shiboski CH, Shiboski SC, le Seror R, 
Criswell LA, Labetoulle M, Lietman TM, 
et al. American College of Rheumatology/
European League Against Rheumatism 
Classification Criteria for Primary 
Sjögren’s Syndrome. A consensus and 
data-driven methodology involving three 
international patient cohorts. Annals of 
the Rheumatic Diseases. 2017;76:9-16
[3] Mavragani CP, Moutsopoulos HM. 
Sjögren’s syndrome. Annual Review 
of Pathology: Mechanisms of Disease. 
2014;9:273-285
[4] Daniels TE, Cox D, Shiboski CH, 
Schiødt M, Wu A, Lanfranchi H, et al. 
Greenspan JS and for the Sjögren’s 
international collaborative clinical 
Alliance (SICCA) research groups. 
Associations between salivary gland 
histopathologic diagnoses and 
phenotypic features of Sjögren’s 
syndrome (SS) among 1726 registry 
participants. Arthritis and Rheumatism. 
2011;63:2021-2030
[5] Pereira DL, Vilela VS, Dos Santos TC, 
Pires FR. Clinical and laboratorial 
profile and histological features on 
minor salivary glands from patients 
under investigation for Sjögren’s 
syndrome. Medicina Oral, Patología 
Oral y Cirugía Bucal. 2014;19:e237-e241
[6] Kim J, Sun D, Ozl R, Graderbeck T, 
Birnbaum J, Akpek EK, et al. A validated 
method of labial minor salivary gland 
biopsy for the diagnosis of Sjögren’s 
syndrome. The Laryngoscope. 
2016;126:2041-2046
[7] Kroese F, Haacke E, 
Bombardieri M. The role of salivary 
gland histopathology in primary 
Sjögren’s syndrome: Promises and 
pitfalls. Clinical and Experimental 
Rheumatology. 2018;36(Suppl 112): 
222-233
[8] Delli K, Vissink A, Spijkervet FKL. 
Salivary gland biopsy for Sjögren’s 
syndrome. Oral and Maxillofacial 
Surgery Clinics of North America. 
2014;26(1):23-33
[9] Franceschini F, Cavazzana I, 
Andreoli L, Tincani A. The 2016 
classification criteria for primary 
Sjogren’s syndrome: What’s new? BMC 
Medicine. 2017;15:69
[10] Sarioğlu S, Küҫük Ŭ, Cetin P, 
Sari I, Bĭrlĭk AM. Minor salivary gland 
evaluation: Sjögren’s syndrome. Turk J 
Med Sci. 2016;46:63-65
[11] Varela-Centelles P, Sanchez-
Sanchez M, Seoane J. Lip biopsy for the 
diagnosis of Sjögren’s syndrome: Beware 
of the punch. International Journal 
of Oral and Maxillofacial Surgery. 
2014;43(1):127-130
[12] Giovelli RA, Santos MCS, Serrano E, 
Valim V. Clinical characteristics and 
biopsy accuracy in suspected cases 
of Sjögren’s syndrome referred to 
labial salivary gland biopsy. BMC 
Musculoskeletal Disorders. 2015;16:30
[13] Bamba R, Sweiss NJ, Langerman AJ, 
Taxy JB, Blair EA. The minor salivary 
gland biopsy as a diagnostic tool for 
Sjögren’s syndrome. The Laryngoscope. 
2009;119:1922-1926
[14] Langerman AJ, Blair EA, Sweiss NJ, 
Taxy JB. Utility of lip biopsy in the 
diagnosis and treatment of Sjögren’s 
syndrome. The Laryngoscope. 
2007;117(6):1004-1008
[15] Van Stein-Callenfels D, Tan J, 
Bloemena E, van Vugt RM, Voskuyl 
Chronic Autoimmune Epithelitis - Sjogren’s Syndrome and Other Autoimmune Diseases...
14
AE, Santana NT, et al. The role of 
labial salivary gland biopsy in the 
diagnostic procedure for Sjögren’s 
syndrome; a study of 94 cases. Medicina 
Oral, Patología Oral y Cirugía Bucal. 
2014;19(4):e372-e376
[16] Tarpley TM Jr, Anderson LG, 
White CL. Minor salivary gland 
involvement in Sjögren’s syndrome. 
Oral Surgery, Oral Medicine, and Oral 
Pathology. 1974;37(1):64-74
[17] Chisholm DM, Mason DK. Labial 
salivary gland biopsy in Sjögren’s 
disease. Journal of Clinical Pathology. 
1968;21(5):656-660
[18] Keszler A, Adler LI, Gandolfo MS, 
Masquijo Bisio PA, Smith AC, 
Vollenweider CF, et al. MALT lymphoma 
in labial salivary gland biopsy from 
Sjögren syndrome: Importance of 
follow-up in early detection. Oral 
Surgery, Oral Medicine, Oral Pathology, 
Oral Radiology. 2013;115:e28-e33
[19] Theander E, Vasaitis L, 
Baecklund E, Nordmark G, 
Warfvinge G, Liedholm R, et al. 
Lymphoid organisation in labial salivary 
gland biopsies is a possible predictor 
for the development of malignant 
lymphoma in primary Sjögren’s 
syndrome. Annals of the Rheumatic 
Diseases. 2011;70:1363-1368
[20] Bende RJ, Slot LM, Hoogeboom R, 
Wormhoudt TA, Adeoye AO, 
Guikema JE, et al. Stereotypic 
rheumatoid factors that are frequently 
expressed in mucosa-associated 
lymphoid tissue-type lymphomas 
are rare in the labial salivary 
glands of patients with Sjögren’s 
syndrome. Arthritis & Rhematology. 
2015;67:1074-1083
[21] Ferro F, Marcucci E, Orlandi M, 
Baldini C, Bartoloni-Bocci E. One 
year in review 2017: Primary Sjögren’s 
syndrome. Clinical and Experimental 
Rheumatology. 2017;35:179-191
[22] Fragoulis GE, Fragkioudaki S, 
Reilly JH, Kerr SC, McInnes IB, 
Mautsopoulos HM. Analysis of the 
cell populations composing the 
mononuclear cell infiltrates in the labial 
minor salivary glands from patients 
with rheumatoid arthritis and sicca 
syndrome. Journal of Autoimmunity. 
2016;73:85-91
[23] Soyfoo MS, Catteau X, Delporte C. 
Parotid gland biopsy as an additional 
diagnostic tool for supporting the 
diagnosis of Sjögren’s syndrome. 
International Journal of Rheumatology. 
2011:302527
[24] Pijpe J, Kalk WWI, van der Wal JE, 
et al. Parotid gland biopsy compared with 
labial biopsy in the diagnosis of patients 
with primary Sjögren’s syndrome. 
Rheumatology. 2007;46(10):335-341
[25] de Sousa Gomes P, Juodzbalys G, 
Fernandes MH, Guobis Z. Diagnostic 
approaches to Sjögren’s syndrome: 
A literature review and own clinical 
experience. Journal of Oral & 
Maxillofacial Research. 2012;3(1):e3
[26] Błochowiak K, Wyganowska-
Światkowska M. Labial minor salivary 
gland biopsy in the diagnosis of Sjögren 
syndrome-own experience. Dent 
Forum. 2018;46(2):17-21
[27] Scardina GA, Spanó G, Carini F, 
et al. Diagnostic evaluation of serial 
sections of labial salivary gland biopsies 
in Sjögren’s syndrome. Medicina 
Oral, Patología Oral y Cirugía Bucal. 
2007;12:565-568
[28] Błochowiak K, Olewicz-Gawlik A, 
Polańska A, Nowak-Gabryel M, 
Kocięcki J, Witmanowski H, et al. Oral 
mucosal manifestations in primary and 
secondary Sjögren syndrome and dry 
mouth syndrome. Postȩpy Dermatologii 
i Alergologii. 2016;33:23-27
[29] Öztürk AB, Öztürk E, Kasapoğlu E. 
Chronic cough due to mucosal dryness 
15
Laryngological and Dental Manifestations of Sjögren’s Syndrome
DOI: http://dx.doi.org/10.5772/intechopen.85687
in primary Sjögren’s syndrome: A 
case report. Tüberküloz ve Toraks. 
2014;62:243-244
[30] Kumon Y, Kakigi A, Sugiura T. 
Clinical images: Otalgia, an unusual 
complication of Sjögren’s syndrome. 
Arthritis and Rheumatism. 
2009;60:2542
[31] Fox RI. Sjögren’s syndrome. Lancet. 
2005;366:321-331
[32] Calzada AP, Balaker AE, Ishiyama G, 
Lopez IA, Ishiyama A. Temporal bone 
histopathology and immunoglobulin 
deposition in Sjogren’s syndrome. 
Otology & Neurotology. 2012;33:258-266
[33] Kamiński B. Laryngological 
manifestations of Sjögren’s syndrome. 
Reumatologia/Rheumatology. 
2019;57(1):37-44
[34] Kim KS, Kim HS. Successful 
treatment of sensorineural hearing 
loss in Sjögren’s syndrome with 
corticosteroid. The Korean Journal of 
Internal Medicine. 2016;31:612-615
[35] Ramos-Casals M, Tzioufas AG, 
Font J. Primary Sjögren’s syndrome: 
New clinical and therapeutic concepts. 
Annals of the Rheumatic Diseases. 
2005;64:347-354
[36] Hadithi M, Stam F, Donker AJ, 
Dijkmans BA. Sjögren’s syndrome: 
An unusual cause of Bell’s palsy. 
Annals of the Rheumatic Diseases. 
2001;60:724-725
[37] Ashraf VV, Bhasi R, Kumar RP, 
Girija AS. Primary Sjögren’s syndrome 
manifesting as multiple cranial 
neuropathies: MRI findings. Annals 
of Indian Academy of Neurology. 
2009;12:124-126
[38] Sakai K, Hamaguchi T, Yamada M. 
Multiple cranial nerve enhancement 
on MRI in primary Sjögren’s syndrome. 
Internal Medicine. 2010;49:857-859
[39] Tucci M, Quatraro C, 
Silvestris F. Sjögren’s syndrome: 
An autoimmune disorder with 
otolaryngological involvement. 
Acta Otorhinolaryngologica Italica. 
2005;25:139-144
[40] Birnbaum J. Facial Weakness, 
Otalgia, and Hemifacial Spasm: A Novel 
Neurological Syndrome in a Case-Series 
of 3 Patient
